Looking for an ADHD Summer Camp or School? Call Toll Free 866.828.1678

Study: Popular ADHD Meds Don't Increase Cancer Risk

Three widely prescribed medications for Attention Deficit Hyperactivity Disorder - Ritalin, Concerta and Adderall - do not cause genetic damage linked to an increased risk of cancer, according to research from Duke University. This new study refutes a previous one that showed that methylphenidate, the active ingredient in Ritalin and Concerta, is associated with increased risk for cancer.

The new Duke study used a larger sample size and a wider cross-section of children with Attention Deficit Disorder compared to previous studies.

"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race, and ADHD subtype," said author Scott Kollins. Kollins was referring to methylphenidate and amphetamine, the active ingredient in Adderall.

About two million American children have Attention Deficit Hyperactivity Disorder.

This study appeared in the Journal of the American Academy of Child & Adolescent Psychiatry.

Labels: medications, side_effects, cancer

Posted By: Aspen Education Group